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Discussion
DrOttavio Alfieri (Milan, Italy). This study, very well presented by
Dr Voeller, is another important contribution coming from a leading
institution with a great tradition and an ongoing prominent scientific
production in the field of surgical treatment of AF. The Coxmaze III
operation has been repeatedly and consistently shown to be the most
effective curative therapy for AF. Although the reproduction of the
standard cut-and-sew procedure using bipolar radiofrequency to
create atrial lesions has been associated with similar results in a pro-
pensity analysis conducted by the authors, this has not been the case
in other experiences.
At the Mayo Clinic, for instance, the superiority of the cut-and-
sew method over the radiofrequency variant has been clearly docu-
mented in a case-matched study. Therefore efforts to increase the
effectiveness of the bipolar radiofrequency ablation procedure, the
so-called Cox maze IV operation, are fully justified.
There are several reasons to believe that the addition of a second
connecting line is a good move. First, the box lesion is mimicking
more closely the original cut-and-sew Cox maze III operation, in
which a large incision is encircling all 4 pulmonary veins.
Second, the box lesion is achieving a more considerable reduc-
tion of the critical mass necessary to sustain AF.
Third, the posterior free wall of the left atrium is recognized as
a common site of nonpulmonary vein triggers of AF.
Fourth, it is always possible that the single connecting ablation
line is not producing a complete transmural lesion. Although we
are generally confident to produce transmural lesions with bipolar
radiofrequency, we never know for sure, particularly when the atrial
wall is thick, fibrotic, and with a lot of fatty tissue. Furthermore, the
transmurality of that connecting line, which is created on an arrested
heart, is never evaluated electrophysiologically.
Fifth, it is likely that a complete isolation of the posterior left
atrium is producing more functional exclusion of epicardial gangli-
onated plexuses, which has been recognized to have a role in the ini-
tiation and maintenance of AF.
I have a couple of questions for Dr Voeller. First, the negative
aspect of the box lesion is the possible adverse effect on left atrial
function because a large area of akinetic electrically isolated left
atrium is created. Did you investigate the left atrial function with
specific methods in the 2 groups of patients?
My other question is related to the use of antiarrhythmic drugs. A
significant reduction in the use of antiarrhythmic drugs was obtained
in the box lesion groups at 3 and 6 months’ follow-up. This is an
important achievement, which is convincing only if precise and rig-
orous protocols of antiarrhythmic drug administrations are consis-
tently applied over time. Can you tell us which have been the
criteria to give and to stop the antiarrhythmic drugs in your study?
Thank you, and again, congratulations for this excellent article.
Dr Voeller. Thank you, Dr Alfieri, for your kind words. We feel
very honored to have you discuss our studies, and those are excellent
questions. To try to answer your first question, obviously our overall
goal is to do an operation that has a high success rate yet preserves
the normal left atrial function physiologically and mechanically as
much as possible, and there is no question that doing a Cox maze
procedure does have some sort of effect on left atrial function. Un-
fortunately, there are not a lot of studies out there that have system-
atically and in detail looked at this question. We are actually in the
process of looking at this clinically and experimentally using nonin-
vasive magnetic resonance imaging.
Could have my slide up once again please? We do have some
preliminary data from 3 maze patients who underwent preoperative
and 30-day postoperative cardiac magnetic resonance imaging to
look at atrial function and how that is affected from the Cox maze
procedure, and our preliminary results show that reservoir function,
as well as booster pump function, are both negatively affected to
a certain extent at least 30 days after the operation. The conduit
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function actually picks up the diminished reservoir and booster
pump function. Therefore the maze procedure does have a negative
effect on atrial function, and further studies are necessary and more
data are required to really know what happens to atrial function and
how long the negative effects persist after the maze procedure.
Having said that, these negative effects on atrial function proba-
bly do not have a large clinical meaning in patients, at least those
with a structurally normal heart with normal left ventricular func-
tion, but that is sort of early to say.
With regard to the posterior left atrium specifically, the reason
why we initially did not do a box lesion early in this series was
because of the fear that producing an akinetic posterior wall by iso-
lating the posterior left atrium, which accounts for about a third of
the total left atrial mass, created a negative effect on the overall
left atrial function, and some authors have actually further stated
that this could actually create an environment for thrombus forma-
tion and put the patient at risk of stroke. However, having said
that, in our experience of doing the Cox maze procedure at
Barnes-Jewish Hospital for 20 years now, our incidence of postop-
erative stroke has been extremely low, less than 0.1% per year, and
at long-term follow-up, well over 90% of our patients are off warfa-
rin. Therefore we are pretty confident that this posterior left atrial
wall akinesis caused by the box lesion has very little clinical signif-
icance, at least in our experience.
To try to answer your second question, we do have strict guide-
lines in terms of antiarrhythmic use after the operation. In patients
who are in normal sinus rhythm after the operation, those patients
are all started on antiarrhythmic drugs, preferably amiodarone, for
2 months. Patients obviously in AF after the operation are also
started on antiarrhythmic drugs. For patients who are in bradycardia
or junctional rhythm, we do not start them on antiarrhythmic drugs
routinely.
At 2 months we obtain an electrocardiogram, and if the patients
are in normal sinus rhythm at that point, we stop the antiarrhythmic
drugs at 2 months. Four weeks after that, so at 3 months’ follow-up,
we get a 24-hour prolonged Holter monitoring at this time, and if
they still remain in sinus rhythm, we stop the warfarin at that point,
at 3 months.
Dr Niv Ad (Falls Church, Va). This is an excellent study and
a very important one. I wonder whether you looked at the subgroup
of patients in whom the nonboxed lesion failed in more detail. In
other words, were they different and more prone to failure with re-
gard to the existence of the number of traditional risk factors for fail-
ure? That is to say, this study might miss the real reason for failure
because of the fact that those variables were not assessed: larger
atria, longer duration of AF, or both. Our practice is to apply the
nonboxed lesion in so-called regular-sized or a little bit oversized
left atria; however, we use a full box lesion and more in those pa-
tients with larger atria. Did you find any correlation?
Dr Voeller. In terms of left atrial size and failure?
Dr Ad. In this specific subgroup of patients in whom failure
occurred, did they have larger atria and longer durations of AF
that might suggest that it is not the lesion that was the strongest pre-
dictor for failure but the subset of patients? I think that this is a very
important group and more interesting than many other groups that
we are reporting about.
Dr Voeller. We did not look at that specifically. As you men-
tioned, the left atrial size was slightly smaller in the box lesion
group. The mean size was 5.3 cm, as opposed to 5.8 cm in the non-
box lesion group. But we did not investigate your specific question
in this study.
Dr Takashi Nitta (Tokyo, Japan). Your data have proved the
hypothesis of mass theory in AF. The more atrium you isolate, the
higher success rate for AF you get. But we also have to think about
left atrial function, as Dr Alfieri has noted, because the purpose of
AF surgery is not only in the restoration of sinus rhythm but also
in the restoration of significant left atrial transport function to pre-
vent thromboembolic events.
We have shown in an animal study that isolation of the posterior
left atrium results in about a 20% to 30% reduction of the left atrial
transport function compared with bilateral pulmonary vein isolation.
For this reason, I think it is too early to conclude that the box lesion
should be performed in all patients undergoing the Cox maze proce-
dure. I think you can map the posterior left atrium with a mapping
system to define the patients in whom we really need to isolate
the posterior left atrium. Have you ever mapped the patients to
examine whether abnormal activation or reentry arises from the
posterior left atrium?
Dr Voeller. We clinically have not done that.
Dr Damiano. Dr Nitta, what you are asking is whether we have
ever performed intraoperative mapping?
Dr Nitta. Right. Your data have suggested that some patients
might have some kind of triggers or reentry in the posterior left
atrium. Have you ever proved that electrophysiologically?
Dr Damiano. We have performed intraoperative mapping on
between 50 and 60 patients over the years, and we have definitely
seen rotors that have involved areas of the posterior left atrium,
but as opposed to your group, we have not used it to guide therapy
in any way. Most of our maps are generated retrospectively. But
clearly, we have shown, as have many others, as Dr Alfieri pointed
out, that the posterior left atrium is an important site of triggers, non–
pulmonary vein triggers, for paroxysmal AF. We have also seen,
both in our intraoperative mapping and now in body-surface map-
ping, that this area is very involved in the creation and maintenance
of the rotors, which are involved in sustained atrial function.
Dr Masashi Komeda (Kyoto, Japan). Anatomy teaches us that
the posterior left atrial wall, the area surrounded by those 4 pulmo-
nary vein orifices, is embryologically a part of the pulmonary vein,
and thus there is not much muscle. Therefore basically creating
a box lesion does not compromise left atrial function so much. In
our atrial volume reduction maze surgery, we just ignore the func-
tion of that posterior left atrial part, but we still have good results.
Just a comment.
Dr Voeller. Thank you very much for that comment. I actually
had a slide that I wanted to show you from a magnetic resonance
imaging study looking at the 4-chamber view of the heart, and it
clearly shows that the posterior portion of the left atrium does
not move under normal circumstances, or the movement is very
little, because the posterior wall is tethered to the posterior medi-
astinum by the pulmonary veins. But creating a box lesion and cre-
ating that area being akinetic, it probably has very little mechanical
consequence.
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